Skip to main content
Midas Edge

Valneva SE

For the period ended Mar 31, 2026. Filed May 13, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Mar 31, 2026 · Filed May 13, 2026

Use the contents to explore the available documents and sections.

VALN$5.51-2.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.1 · Clinical Stage Programs

Clinical Stage Programs

LYME DISEASE VACCINE CANDIDATE – LB6V (formerly VLA15)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.